Atropine Sulfate 2 mg/mL Sublingual Solution is a liquid formulation designed for sublingual administration, dispensed in a dropper bottle for precise dosing. This solution facilitates rapid absorption through the sublingual mucosa, ensuring efficient delivery of atropine sulfate into the bloodstream. It is used to treat conditions such as bradycardia, organophosphate poisoning, and to reduce salivation and respiratory secretions during surgery. The sublingual route provides fast-acting effects by bypassing the digestive system.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Atropine Sulfate 2 mg/mL Sublingual Solution is a specialized liquid medication formulated for administration under the tongue. Dispensed in a dropper bottle, this solution allows for precise and controlled dosing, facilitating rapid absorption of atropine sulfate into the bloodstream through the highly vascularized sublingual mucosa. By bypassing the digestive system, this delivery method provides efficient and targeted therapeutic effects with a faster onset of action compared to oral administration.
Atropine sulfate is an anticholinergic agent that works by inhibiting the action of acetylcholine on smooth muscles and glands innervated by parasympathetic nerves. It is commonly used in medical settings to reduce salivation and bronchial secretions before surgery, manage bradycardia (slow heart rate), and as an antidote for certain types of poisonings involving organophosphates or muscarinic mushroom toxins.
The sublingual administration of atropine sulfate is particularly beneficial when a rapid increase in heart rate is desired or when reducing secretions is necessary without the delay associated with oral absorption. The convenience of the dropper bottle enhances patient compliance and allows for ease of use in both clinical and home settings.
For prescribers, this formulation offers a reliable alternative for patients who may have difficulty swallowing pills or require immediate therapeutic effects. It is important to assess the patient's medical history, including any hypersensitivity to atropine or other anticholinergic agents, glaucoma, prostatic hypertrophy, or obstructive diseases of the gastrointestinal or urogenital tracts.
Patients should use Atropine Sulfate 2 mg/mL Sublingual Solution exactly as prescribed by their healthcare provider. The precise dosing facilitated by the dropper bottle ensures that patients receive the intended amount of medication, minimizing the risk of adverse effects. Common side effects may include dry mouth, blurred vision, sensitivity to light, lack of sweating, dizziness, nausea, and constipation. If any of these effects persist or worsen, patients should contact their healthcare provider promptly.
It is crucial for patients to inform their healthcare provider about all other medications they are taking, including over-the-counter drugs and herbal supplements, to prevent potential drug interactions. Alcohol consumption should be discussed with the healthcare provider, as it may enhance certain side effects of atropine.
If you have any questions or require further information about Atropine Sulfate 2 mg/mL Sublingual Solution, please reach out to us.
Atropine Sulfate 2 mg/mL Sublingual Solution is a potent anticholinergic agent that is used in various clinical settings, including the management of bradycardia, organophosphate poisoning, and as a pre-anesthetic to reduce salivation. When considering the use of this formulation, it is crucial to be aware of potential drug interactions that may affect its efficacy or increase the risk of adverse effects.
Concomitant use of atropine with other anticholinergic drugs, such as scopolamine, antihistamines, tricyclic antidepressants, and certain antipsychotics, can lead to additive anticholinergic effects. This may result in increased risk of side effects such as dry mouth, blurred vision, constipation, urinary retention, and confusion, particularly in elderly patients. It is important for prescribers to assess the cumulative anticholinergic burden when these medications are used together and adjust dosages accordingly.
Atropine may also interact with medications that affect heart rate and rhythm. For instance, when used with beta-blockers or calcium channel blockers, there may be an unpredictable effect on heart rate, potentially leading to either bradycardia or tachycardia. Close monitoring of cardiac function is advised when these drugs are co-administered.
Patients taking medications that lower seizure threshold, such as bupropion or certain antipsychotics, should be monitored closely, as atropine can potentially exacerbate this effect. Additionally, atropine may reduce the effectiveness of medications used to treat myasthenia gravis, such as pyridostigmine, due to its anticholinergic properties. Patients with myasthenia gravis should be carefully monitored, and dosage adjustments may be necessary.
Atropine can also interact with medications that affect gastrointestinal motility. For example, it may reduce the absorption of oral medications by slowing gastric emptying. This is particularly relevant for drugs with a narrow therapeutic index, where precise dosing is critical. Prescribers should consider alternative routes of administration or adjust dosing schedules to mitigate this interaction.
Alcohol and other central nervous system depressants may enhance the sedative effects of atropine, leading to increased drowsiness and impaired cognitive function. Patients should be advised to avoid alcohol and be cautious with activities requiring mental alertness, such as driving or operating machinery, while using this medication.
For patients and prescribers considering the use of Atropine Sulfate 2 mg/mL Sublingual Solution, it is essential to conduct a thorough medication review to identify potential interactions and adjust treatment plans accordingly. If you have any questions or need further assistance, please reach out to us at Bayview Pharmacy.
Atropine Sulfate 2 mg/mL Sublingual Solution is a specialized liquid formulation designed for sublingual administration, meaning it is placed under the tongue for absorption. This method of delivery is particularly advantageous due to the rich vascularization of the sublingual mucosa, which allows for rapid absorption of the medication directly into the bloodstream. By bypassing the digestive system, the sublingual route avoids first-pass metabolism in the liver, leading to a quicker onset of action compared to oral administration. This can be particularly beneficial in situations where fast-acting effects are desired or when the patient has difficulty swallowing pills.
The formulation is dispensed in a dropper bottle, which facilitates precise and controlled dosing. This is crucial for medications like Atropine Sulfate, where accurate dosing is essential to achieve the desired therapeutic effects while minimizing potential side effects. The dropper allows patients or caregivers to administer the exact amount prescribed by the healthcare provider, ensuring consistency in treatment.
Atropine Sulfate is an anticholinergic agent that works by blocking the action of acetylcholine, a neurotransmitter involved in the activation of the parasympathetic nervous system. By inhibiting acetylcholine, atropine reduces secretions, relaxes smooth muscles, and increases heart rate, among other effects. This makes it useful in treating a variety of conditions. For instance, it can be used to manage bradycardia (abnormally slow heart rate) by increasing the heart rate. It is also employed in the treatment of organophosphate poisoning, where it counteracts the excessive muscarinic effects caused by the accumulation of acetylcholine.
In addition to these uses, atropine may be prescribed for other conditions as determined by a healthcare provider. The sublingual formulation is particularly useful in emergency situations or when rapid symptom relief is necessary. It is also beneficial for patients who have gastrointestinal issues that might impair the absorption of oral medications.
For prescribers, it is important to consider the patient's overall health status, potential drug interactions, and specific therapeutic goals when prescribing Atropine Sulfate 2 mg/mL Sublingual Solution. Patients should be advised on the correct administration technique to ensure optimal absorption and efficacy. As with any medication, monitoring for side effects is essential, and patients should be instructed to report any adverse reactions or concerns promptly.
If you have any questions about this formulation or its use in treating specific conditions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to ensure the best possible outcomes for your patients.
Atropine Sulfate 2 mg/mL Sublingual Solution is used for its anticholinergic properties, which can help manage conditions such as bradycardia (slow heart rate), reduce salivation and respiratory secretions, and as an antidote for certain types of poisoning.
This solution is administered under the tongue using a dropper bottle. The sublingual route allows for rapid absorption into the bloodstream through the mucous membranes.
The sublingual route is preferred because it allows for fast-acting effects by bypassing the digestive system and liver metabolism, leading to quicker absorption into the bloodstream.
Store the Atropine Sulfate sublingual solution in a cool, dry place away from direct sunlight. Ensure the bottle is tightly closed to maintain its efficacy and prevent contamination.
It is recommended to avoid eating or drinking for at least 10-15 minutes after administration to ensure optimal absorption of the medication.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
Possible side effects include dry mouth, blurred vision, sensitivity to light, dizziness, and increased heart rate. If you experience severe side effects, contact your healthcare provider immediately.
Consult your healthcare provider before using Atropine Sulfate sublingual solution if you are pregnant or breastfeeding to ensure it is safe for you and your baby.
Before using this medication, inform your healthcare provider about all other medications you are taking, as Atropine Sulfate can interact with other drugs, potentially altering their effects.
In case of an overdose, seek immediate medical attention. Symptoms of overdose may include confusion, hallucinations, severe drowsiness, or difficulty breathing.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place dropper amount under the tongue